[1] ULLAH R,RAUF N,NABI G,et al.Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease:Recent updates[J].International Journal of Biological Sciences,2019,15(2):265-276. [2] HAN X,TAI H,WANG X,et al.AMPK activation protects cells from oxidative stress-induced senescence via autophagic flux restoration and intracellular NAD+ elevation[J].Aging Cell,2016,15(3):416-427. [3] SWATI P,UDDIPAK R,RAMOJI K,et al.Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice[J].Biochimie,2020,168:198-209. [4] VALENZUELA R,ORTIZ M,HERNÁNDEZ-RODAS M C,et al.Targeting n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease[J].Current Medicinal Chemistry,2020,27(31):5250-5272. [5] SHENG Y,LIU J,ZHENG S,et al.Mulberry leaf activates brown adipose tissue and induces browning of inguinal white adipose tissue in type 2 diabetic rats through regulating AMPK signaling pathway[J].British Journal of Nutrition,2019,10(8):4771-4781. [6] YANG J,SÁINZ N,FÉLIX-SORIANO E,et al.Effects of long-term DHA supplementation and physical exercise on non-alcoholic fatty liver development in obese aged female mice[J].Nutrients,2021,13(2):501. [7] 张欣,杨英,安晓羽,等.DHA对高脂食物诱导体重增加的保护作用的研究[J].中国实验动物学报,2020,28(3):376-381. ZHANG X,YANG Y,AN X Y,et al.Protective effects of docosahexaenoic acid supplementation on high-fat diet-induced body weight gain in mice[J].Acta Laboratorium Animalis Scientia Sinica,2020,28(3):376-381.(in Chinese) [8] ORTIZ M,SOTO-ALARCÓN S A,ORELLANA P,et al.Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration[J].Digestive Liver and Disease,2020,52(8):895-904. [9] VALENZUELA R,VIDELA L A.Impact of the co-administration of n-3 fatty acids and olive oil components in preclinical nonalcoholic fatty liver disease models:A mechanistic view[J].Nutrients,2020,12(2):499. [10] KATSNELSON G,CEDDIA R B.Docosahexaenoic and eicosapentaenoic fatty acids differentially regulate glucose and fatty acid metabolism in L6 rat skeletal muscle cells[J].American Journal of Physiology-Cell Physiology,2020,319(6):C1120-C1129. [11] FARRAR J S,LOWNIK J C,WAY G W,et al.Identification of the transgene insertion site for an adipocyte-specific adiponectin-cre model and characterization of the functional consequences[J].Adipocyte,2021,10(1):91-100. [12] HOONG C W S,CHUA M W J.SGLT2 inhibitors as calorie restriction mimetics:Insights on longevity pathways and age-related diseases[J].Endocrinology,2021,162(8):bqab079. [13] ROY B,PALANIYANDI S S.Tissue-specific role and associated downstream signaling pathways of adiponectin[J].Cell Bioscience,2021,11(1):77. [14] WEISS M,FELLMANN L,REGNARD P,et al.Protective effects of the imidazoline-like drug lnp599 in a marmoset model of obesity-induced metabolic disorders[J].International Journal of Obesity,2021,45(6):1229-1239. [15] DECLōVES A E,MATHEW A V,ARMANDO A M,et al.AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice[J].Journal of Lipid Research,2019,60(5):937-952. [16] LAUVAI J,BECKER AK,LEHNERT K,et al.The furan fatty acid 9M5 acts as a partial ligand to peroxisome proliferator-activated receptor gamma and enhances adipogenesis in 3T3-L1 preadipocytes[J].Lipids,2019,54(5):277-288. [17] RAMAIYAN B,TALAHALLI R R.Dietary unsaturated fatty acids modulate maternal dyslipidemia-induced DNA methylation and histone acetylation in placenta and fetal liver in rats[J].Lipids,2018,53(6):581-588. [18] STELLAVATO A,PIROZZI A V A,DE NOVELLIS F,et al.In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model[J].Lipids Health Disease,2018,17(1):24. [19] CHEN L,ZHANG X,ZHANG L,et al.Effect of saxagliptin,a dipeptidyl peptidase 4 inhibitor,on non-alcoholic fatty liver disease[J].Diabetes,Metabolic Syndrome and Obesity:Targets and Therapy,2020,13:3507-3518. [20] KIM M J,KIM D H,BANG E,et al.PPARα agonist,MHY3200,alleviates renal inflammation during aging via regulating ROS/Akt/FoxO1 signaling[J].Molecules,2021,26(11):3197. [21] SOTO-ALARCÓN S A,ORTIZ M,ORELLANA P,et al.Docosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet:A molecular approach[J].Biofactors,2019,45(6):930-943. [22] 姬凯茜,焦丹,谢忠,等.奎棕色脂肪细胞特异基因PRDM16的研究进展与展望[J].中国生物工程杂志,2019,39(4):84-93. JI K X,JIAO D,XIE Z,et al.Advances and prospects of brown adipocyte-specific gene PRDM16[J].China Biotechnology,2019,39(4):84-93.(in Chinese) [23] FLECKENSTEIN-ELSEN M,DINNIES D,JELENIK T,et al.Eicosapentaenoic acid and arachidonic acid differentially regulate adipogenesis,acquisition of a brite phenotype and mitochondrial function in primary human adipocytes[J].Molecular Nutrition Food Research,2016,60(9):2065-2075. [24] MAO L,LEI J,SCHOEMAKER M H,et al.Long-chain polyunsaturated fatty acids and extensively hydrolyzed casein-induced browning in a UCP-1 reporter mouse model of obesity[J].Food & Function,2018,9(4):2362-2373. [25] WU L,JIAO Y,LI Y,et al.Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α[J].Journal of Experimental Medicine,2021,218(5):e20201475. |